Article info

Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study

Authors

  1. Correspondence to Dr Francesco Trotta; f.trotta{at}aifa.gov.it
View Full Text

Citation

Trotta F, Da Cas R, Rajevic M, et al
Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study

Publication history

  • Received September 12, 2014
  • Revised October 30, 2014
  • Accepted November 5, 2014
  • First published May 25, 2015.
Online issue publication 
May 25, 2015
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.